Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteomics of heart of adult mice

ABSTRACT: Proteomics of heart of mouse which is treated with Immune checkpoint inhibitors

ORGANISM(S): Mus Musculus

SUBMITTER: Pei Wang

PROVIDER: PXD031720 | iProX | Wed Feb 16 00:00:00 GMT 2022

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Tsur2019 - Response of patients with melanoma to immune checkpoint blockade

Project description:This is a simple mathematical population model for pembrolizumab-treated advanced melanoma patients, used to predict the response of melanoma patients to immune checkpoint inhibitors.

2024-09-02 | BIOMD0000000838 | BioModels

Identifying genomic predictors of sensitivity to immune checkpoint therapy in mouse models of TNBC

Project description:We created new mouse mammary tumor models to identify biomarkers of sensitivity to immune checkpoint inhibitors. Using these models in a syngeneic transplant system and treating with anti-PD1/anti-CTLA4 combination therapy, we profiled treated and non-treated tumors by RNA-SEQ. Herein, the profiled tumors represent models that are resistant or senstitive to immune checkpoint inhibitors at distinct timepoints of therapy and tumor progression.

2019-11-13 | GSE124821 | GEO

Transcriptome analysis of aging mouse heart compared with adult heart

Project description:Transcriptome analysis of aging mouse heart compared with adult heart

| PRJNA835808 | ENA

Expression data from adult mouse heart

Project description:Expression data from adult mouse heart

| PRJNA489083 | ENA

Transcriptome analysis of aging mouse heart compared with adult heart

Project description:To identify the gene regulatory network during heart aging, we used the RNA-seq to analyze the gene expression profile difference between adult mouse heart and aging mouse heart.

2023-05-04 | GSE202373 | GEO

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

Project description:Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

| PRJNA1014560 | ENA

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

Project description:Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

| PRJNA1014561 | ENA

Expression data from adult left ventricular heart tissue of hypereosinophilic mice and controls

Project description:Hypereosinophilic syndrome is a progressive disease with extensive eosinophilia that results in organ damage. Patients suffer from frequent cardiac pathologies and a high mortality rate. A better understanding of the mechanisms of eosinophil-mediated tissue damage would benefit the development of new therapies. Here, we describe the cardiac pathologies that develop in a mouse model of hypereosinophilic syndrome. These IL-5 transgenic mice exhibited decreased left ventricular function already at a young age. Cardiac function worsened with age and heart weight increased. Moreover, hypereosinophilic mice developed different pathologies of the cardiac conductive system, including 2nd degree atrioventricular block and atrioventricular reentry. Cardiomyocytes from IL-5 transgenic mice showed reduced contractility. Despite immune infiltrates in the lungs, doppler echocardiography revealed no signs of pulmonary hypertension in these mice. Mechanistically, we demonstrated eosinophil infiltration of the heart tissue that lead to an inflammatory environment. Eosinophils were 100-fold more abundant in the hearts of hypereosinophilic mice than controls. Gene expression signatures showed tissue damage as well as repair and remodeling processes. Our results suggest that hypereosinophilia leads to infiltration of the heart tissue by eosinophils and tissue damage. The ongoing remodeling and repair processes are insufficient or maladapted to maintain heart function resulting in progressive deterioration.

2023-10-25 | GSE185300 | GEO

human gut metagenome

Project description:Microbiome study of Japanese cancer patients treated with immune checkpoint inhibitors

| PRJDB17628 | ENA

Plasma proteomic profiles of SCLC patients treated with ICIs combined with anti-angiogenic therapy as second- or further-line treatment

Project description:Plasma proteomic profiles of small cell lung cancer patients treated with immune checkpoint inhibitors combined with anti-angiogenic therapy as second- or further-line treatment

2025-02-25 | PXD061159 |

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data